Drug application
PHENTERMINE RESIN COMPLEX (PHENTERMINE RESIN COMPLEX)
Drugs@FDA ANDA 040872 · LANNETT CO INC
Key facts
| Drug name | PHENTERMINE RESIN COMPLEX |
|---|---|
| Active ingredients | PHENTERMINE RESIN COMPLEX |
| Application type | ANDA |
| Application number | 040872 |
| Company | LANNETT CO INC |
| Dosage forms | CAPSULE, EXTENDED RELEASE, ORAL |
| Strength | EQ 15MG BASE |
| Marketing status | Discontinued |
| Reference listed drug | No |
| Latest submission status date | Jul 28, 2011 |
At a glance
- 1–9 Submissions
- 1–9 Supplements
- None Label versions
- 1–9 Products
- None Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.